ArticleEmerging infectious diseases2014
Prevalence of Arcobacter species among humans, Belgium, 2008-2013.
Article in Emerging infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Immunopathogenic Potential of Arcobacter butzleri - Lessons from a Meta-Analysis of Murine Infection Studies.PloS one · 2016Pooled it
- Identification of biofilm-associated genes inBiofilm · 2026Article
- The microbiological and clinical characteristics of 1,204 human cases of Aliarcobacter spp. infections that occurred in France between 2002 and 2024.Gut pathogens · 2025Article
- Pathogenicity of Arcobacter cryaerophilus in two human intestinal cell lines.Gut pathogens · 2025Article
- Chemical Composition and Antibacterial Effect of Clove and Thyme Essential Oils on Growth Inhibition and Biofilm Formation ofAntibiotics (Basel, Switzerland) · 2024Article
- Arcobacter species isolated from human stool samples, animal products, ready-to-eat salad mixes, and ambient water: prevalence, antimicrobial susceptibility, and virulence gene profiles.BMC infectious diseases · 2024Article
- Isolation and Detection of the Emerging PathogenMicroorganisms · 2024Article
- Evaluation of Bile Salts on the Survival and Modulation of Virulence ofAntibiotics (Basel, Switzerland) · 2023Article
- Widespread Multidrug Resistance ofAntibiotics (Basel, Switzerland) · 2023Article
- Article
- Genomic Characterization ofMicroorganisms · 2023Article
- Genomic diversity and taxonomic marker forFrontiers in microbiology · 2023Article
- Effect of Atmospheric Conditions on Pathogenic Phenotypes ofMicroorganisms · 2022Article
- The Prevalence ofPathogens (Basel, Switzerland) · 2022Review
- Genetic characteristics, antimicrobial resistance, and prevalence ofFrontiers in microbiology · 2022Article
- NRJ Media as the Gold-StandardFrontiers in microbiology · 2022Article
- Article
- Biofilm Formation Ability ofMicroorganisms · 2021Article
- Characterization of AreABC, an RND-Type Efflux System Involved in Antimicrobial Resistance of Aliarcobacter butzleri.Antimicrobial agents and chemotherapy · 2021Article
- Natural Transformation as a Mechanism of Horizontal Gene Transfer inPathogens (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We examined fecal samples from 6,774 patients with enteritis in Belgium, 2008-2013. Members of the genus Arcobacter were the fourth most common pathogen group isolated, and the isolation rate was higher than previously reported. Culturing Arcobacter in a microbiology laboratory is feasible and should thus be tested for in cases of diarrheal disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.